SCHEMBL12489451

SCHEMBL12489451

c1ccc(C(CCN2CCN(C(c3ccccc3)c3ccccc3)CC2)c2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.59
DRD3 P35462 3/20 0.59
CYP2D6 P10635 3/20 0.59
CHRM2 P08172 2/20 0.59
CHRM4 P08173 2/20 0.59
CHRM5 P08912 2/20 0.59
ADRA2A P08913 2/20 0.59
ADORA3 P0DMS8 2/20 0.59
CHRM1 P11229 2/20 0.59
CHRM3 P20309 2/20 0.59
DRD1 P21728 2/20 0.59
ADRA1D P25100 2/20 0.59
HTR2A P28223 2/20 0.59
HRH1 P35367 2/20 0.59
HTR2B P41595 2/20 0.59
SLC6A3 Q01959 2/20 0.59
KCNH2 Q12809 2/20 0.59
HTR2C P28335 1/20 0.59
KMT2A Q03164 2/20 0.58
OPRD1 P41143 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5319116 0.91 MEN1 (0.54) OPRM1DRD3CYP2D6CHRM2CHRM4
SCHEMBL172597 0.86 KMT2A (0.62) OPRM1DRD3CYP2D6CHRM2CHRM4
SCHEMBL16227208 0.83 CYP2D6 (0.67) CYP2D6CHRM2CHRM1KCNA3ALDH1A1
SCHEMBL8371746 0.82 OPRM1 (0.59) OPRM1DRD3CYP2D6CHRM2CHRM4
SCHEMBL1491229 0.82 OPRD1 (0.65) OPRM1DRD3CYP2D6CHRM2CHRM4
SCHEMBL4249388 0.82 LMNA (0.60) OPRM1DRD3CYP2D6CHRM2CHRM4
SCHEMBL8371748 0.82 OPRD1 (0.67) OPRM1DRD3CYP2D6CHRM2CHRM4
SCHEMBL7381083 0.82 DRD3 (0.60) OPRM1DRD3CYP2D6CHRM2CHRM4
SCHEMBL7963339 0.82 DRD3 (0.59) OPRM1DRD3CYP2D6CHRM2CHRM4
SCHEMBL7650625 0.81 OPRM1 (0.54) OPRM1DRD3CYP2D6CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2654726-A1 SOLID DISPERSION FORMULATIONS AND METHODS OF USE THEREOF Zalicus Pharmaceuticals Ltd. (CA) 2013-10-30 EP disclosed
WO-2012122279-A1 SOLID DISPERSION FORMULATIONS AND METHODS OF USE THEREOF ZALICUS PHARMACEUTICALS LTD. (CA) 2012-09-13 WO disclosed